Live Quote · NASDAQGERNHealthcare· Biotechnology

Geron Corporation

$0.87▼ 4.63%($-0.04)
MKT CAP $560.94MNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
61/100
▌ Mixed
60
Valuation
40
Profitability
100
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GERN research report →

Analyst Price Target
$5.89+576.5% vs. today

Range $4 – $8

Analyst RatingBuy
15 Buy7 Hold0 Sell

Price Chart

-20.85% · this period
$1.95$1.41$0.87Nov 20May 26Nov 20
52-Week Range3% of range
Low
$0.84
Current
$0.87
High
$2.01